StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$148.36−1.16 (-0.78%)

Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%

Merck Organon by Quarter

Organon — NuvaRing (contraceptive vaginal ring) International sales ($M) ($M)

QuarterlyAnnual

Merck Organon: $18,000,000M in Q2 2026, down 14.3% from a year earlier.

Latest, Q2 2026
18,000,000
Period ended Jun 30, 2026
Change on a year earlier
-14.3%
21,000,000 in Q2 2025
History
22 quarters
Since Q1 2021
Sources
17
Documents cited below

Where the Q2 2026 figure comes from

Source: Organon & Co. SEC Filing (0001628280-26-051230) ↗

Reported in Organon & Co. Form 10-Q / 10-K (CIK 0001821825).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganon — NuvaRing (contraceptive vaginal ring) International sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202618,000,000-14.3%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2026Mar 31, 202618,000,000+12.5%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q4 2025Dec 31, 202518,000,0000.0%Organon & Co. SEC Filing (0001628280-26-011125) ↗
Q3 2025Sep 30, 202517,000,0000.0%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2025Jun 30, 202521,000,000+10.5%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2025Mar 31, 202516,000,000-27.3%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q4 2024Dec 31, 202418,000,000-5.3%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2024Sep 30, 202417,000,000-15.0%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2024Jun 30, 202419,000,000-17.4%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2024Mar 31, 202422,000,000-8.3%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q4 2023Dec 31, 202319,000,000-5.0%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2023Sep 30, 202320,000,000-13.0%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2023Jun 30, 202323,000,000+15.0%Organon & Co. SEC Filing (0001821825-24-000083) ↗
Q1 2023Mar 31, 202324,000,0000.0%Organon & Co. SEC Filing (0001821825-24-000056) ↗
Q4 2022Dec 31, 202220,000,000-25.9%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2022Sep 30, 202223,000,000-17.9%Organon & Co. SEC Filing (0001821825-23-000013) ↗

Cite this data

StockData. (2026). Merck Organon ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn-nuvaring-intl

See every metric in the Merck KPI table. Data updated Oct 26, 2026.